Welcome to our dedicated page for Arteris SEC filings (Ticker: AIP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Arteris, Inc. (Nasdaq: AIP) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Arteris describes itself as a global leader in system IP used in semiconductors, and its filings offer formal detail on the financial and operational aspects behind that business.
Among the key documents are current reports on Form 8-K, which Arteris uses to furnish press releases announcing quarterly financial results and other material events. For example, the company has filed 8-Ks referencing press releases on results for quarters ended June 30 and September 30, including metrics such as revenue, licensing and royalty performance, operating loss, and Remaining Performance Obligations. These filings give investors structured insight into how Arteris’ licensing, support and maintenance, and variable royalty revenue streams are evolving.
Users can also review other periodic reports, such as Forms 10-Q and 10-K when available, to understand topics like segment performance, risk factors, and detailed financial statements that complement the high-level figures cited in press releases. For those interested in governance and ownership, SEC filings are the place where proxy statements and beneficial ownership reports would appear.
Stock Titan enhances this information by pairing real-time updates from EDGAR with AI-powered summaries that highlight the main points of lengthy filings. Instead of reading every line of a multi-page 10-K or 10-Q, users can rely on AI explanations to quickly identify revenue trends, key risks, and notable changes. The platform also surfaces insider transaction reports on Form 4 when filed, helping investors monitor trading activity by Arteris officers and directors.
By using this page, investors and researchers can efficiently navigate Arteris’ official SEC disclosures, from earnings-related 8-Ks to comprehensive annual and quarterly reports, supported by AI tools that make complex documents easier to interpret.
Arteris, Inc. (AIP) – Form 4 insider transaction
Director S. Atiq Raza reported a sale of 1,136 common shares on 18-Jul-2025 at a reported price of $10.00 per share. The disposition was executed under a previously adopted Rule 10b5-1 trading plan dated 6-Jun-2024.
Following the sale, Raza continues to hold a large position: 682,662 shares held indirectly through the Saiyed Atiq Raza & Nandini Saraiya 2012 Revocable Trust and 20,839 shares held directly. The transaction reduced his total ownership by roughly 0.16%, indicating only a marginal change in economic exposure while maintaining significant alignment with shareholders.
Arteris, Inc. (AIP) – Form 4 insider filing
Director Joachim Kunkel reported the acquisition of 1,727 fully-vested restricted shares of Arteris common stock on 07/05/2025. The shares represent board retainer fees that Mr. Kunkel chose to receive in stock rather than cash; the filing states the director also elected to defer receipt of these shares. The transaction was recorded at a price of $0.00 because it is compensation-related, not an open-market purchase. Following the award, Mr. Kunkel’s direct ownership increases to 66,322 shares. No derivative security activity was reported.
The filing indicates Mr. Kunkel remains classified as a Director and files individually. No amendments or additional reporting persons are noted.
While the award is modest in size, insider share accumulation—especially when taken in lieu of cash—may signal greater alignment with shareholder interests. However, because it is routine compensation rather than a discretionary market purchase, the market impact is likely limited.